1HEPLER C D,STRAND L M.Opportunities and responsibilities in pharmaceutical care[J].Am J Pharm Educ,1990,47 (3):533 -543.
2BHEEKIE A,SYCE J A,WEINBERG E G.Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies[J].J Clin Pharm Ther,2001,70 (26):287-296.
3NA(E)RHI U,AIRAKSINEN M,TANSKANEN P,et al.Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma[J].J Clin Pharm Ther,2000,69(25):177-183.
4CHABOT I,MOISAN J,GR(E)GOIRE J P.Phamatcist intervention program for control of hypertension[J].Ann Pharmacother,2003,37(9):1186-1193.
5GARO J A,CABRITA J.Evaluation of a phamaceutical care program for hypertensive patients in ntral Portugal[J].J Am Pharm Assoc,2002,42(6):858-864.
6MCDONOUGH R P,DOUCETTE W R.Drug therapy management:an empirical report of drug therapy problems,pharmacists'interventions,and results of pharmacists'actions[J].J Am Pharm Assoc,2003,43(4):511-518.
7KARl O L,ROSS T T.Patients'achievement of cholesterol targets A cross-sectional evaluation[J].Am J Prev Med,2003,25 (4):339-342.
8TSUYUKI R T,JOHNSON J A,TEO K K,et al.A randomized trial of the effect of community pharmacist intervention on cholesterol risk management:the study of cardiovascular risk intervention by pharmacists (SCRIP)[J].Arch Intern Med,2002,162(10):1149-1155.
9ROSS T,TSUYUKI K L,OLSON A M,et al.Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events:The second study of cardiovascular risk intervention by pharmacists (SCRIP-plus)[J].Am J Med,2004,116:130-133.
10MANGUM S A,KRAENOW K R,NARDUCCI W A.Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects[J].J Am Pharm Assoc,2003,43(1):50-55.
